Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP258622.RAdM9XbrZlZBb99jtvP9c_lnQS0MpLlapzxbMjq2_eTEQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP258622.RAdM9XbrZlZBb99jtvP9c_lnQS0MpLlapzxbMjq2_eTEQ130_assertion type Assertion NP258622.RAdM9XbrZlZBb99jtvP9c_lnQS0MpLlapzxbMjq2_eTEQ130_head.
- NP258622.RAdM9XbrZlZBb99jtvP9c_lnQS0MpLlapzxbMjq2_eTEQ130_assertion description "[Differentiation from neuroblastoma may be made based on immunoreactivity for beta 2 microglobulin and HBA71 and lack of immunoreactivity for chromogranin in PPNET and MSCT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP258622.RAdM9XbrZlZBb99jtvP9c_lnQS0MpLlapzxbMjq2_eTEQ130_provenance.
- NP258622.RAdM9XbrZlZBb99jtvP9c_lnQS0MpLlapzxbMjq2_eTEQ130_assertion evidence source_evidence_literature NP258622.RAdM9XbrZlZBb99jtvP9c_lnQS0MpLlapzxbMjq2_eTEQ130_provenance.
- NP258622.RAdM9XbrZlZBb99jtvP9c_lnQS0MpLlapzxbMjq2_eTEQ130_assertion SIO_000772 7571088 NP258622.RAdM9XbrZlZBb99jtvP9c_lnQS0MpLlapzxbMjq2_eTEQ130_provenance.
- NP258622.RAdM9XbrZlZBb99jtvP9c_lnQS0MpLlapzxbMjq2_eTEQ130_assertion wasDerivedFrom befree-20150227 NP258622.RAdM9XbrZlZBb99jtvP9c_lnQS0MpLlapzxbMjq2_eTEQ130_provenance.
- NP258622.RAdM9XbrZlZBb99jtvP9c_lnQS0MpLlapzxbMjq2_eTEQ130_assertion wasGeneratedBy ECO_0000203 NP258622.RAdM9XbrZlZBb99jtvP9c_lnQS0MpLlapzxbMjq2_eTEQ130_provenance.